Vijay Divakaran

633 total citations
17 papers, 489 citations indexed

About

Vijay Divakaran is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vijay Divakaran has authored 17 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vijay Divakaran's work include Cardiac Fibrosis and Remodeling (3 papers), Heart Failure Treatment and Management (3 papers) and Cardiac Arrest and Resuscitation (2 papers). Vijay Divakaran is often cited by papers focused on Cardiac Fibrosis and Remodeling (3 papers), Heart Failure Treatment and Management (3 papers) and Cardiac Arrest and Resuscitation (2 papers). Vijay Divakaran collaborates with scholars based in United States, Netherlands and Russia. Vijay Divakaran's co-authors include Douglas L. Mann, Natarajan Sivasubramanian, Masakuni Ishiyama, Sandra B. Haudek, Julia Adrogue, Mark L. Entman, Kenichi Sekiguchi, Amanda L. Chancey, Yasushi Sakata and Jian‐Wen Dong and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and International Journal of Cardiology.

In The Last Decade

Vijay Divakaran

13 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijay Divakaran United States 7 290 225 194 50 36 17 489
Dominika Lukovic Austria 12 261 0.9× 211 0.9× 127 0.7× 81 1.6× 46 1.3× 37 516
Ludovic Malvaux Belgium 6 414 1.4× 215 1.0× 318 1.6× 149 3.0× 20 0.6× 7 671
C. Bombardi Italy 8 219 0.8× 126 0.6× 121 0.6× 44 0.9× 19 0.5× 8 380
Claudia Noack Germany 12 395 1.4× 203 0.9× 44 0.2× 123 2.5× 39 1.1× 21 548
Rui‐Yi Lu China 8 202 0.7× 147 0.7× 107 0.6× 68 1.4× 43 1.2× 13 477
Mariana S. Parahuleva Germany 13 159 0.5× 133 0.6× 126 0.6× 59 1.2× 18 0.5× 45 492
Alexander A. Kremzer Ukraine 17 381 1.3× 221 1.0× 106 0.5× 67 1.3× 81 2.3× 45 625
Changcun Fang China 12 116 0.4× 96 0.4× 106 0.5× 74 1.5× 51 1.4× 21 391
Rebecca Teske United States 6 210 0.7× 69 0.3× 125 0.6× 39 0.8× 45 1.3× 9 385
David P. Hughes United Kingdom 9 228 0.8× 112 0.5× 70 0.4× 144 2.9× 84 2.3× 11 436

Countries citing papers authored by Vijay Divakaran

Since Specialization
Citations

This map shows the geographic impact of Vijay Divakaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay Divakaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay Divakaran more than expected).

Fields of papers citing papers by Vijay Divakaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijay Divakaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay Divakaran. The network helps show where Vijay Divakaran may publish in the future.

Co-authorship network of co-authors of Vijay Divakaran

This figure shows the co-authorship network connecting the top 25 collaborators of Vijay Divakaran. A scholar is included among the top collaborators of Vijay Divakaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay Divakaran. Vijay Divakaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Divakaran, Vijay, et al.. (2024). REVERSE TAKOTSUBO CARDIOMYOPATHY CAUSED BY NEAR-DROWNING. Journal of the American College of Cardiology. 83(13). 3215–3215.
2.
Divakaran, Vijay, et al.. (2020). Anomalous Origin of All Coronary Arteries from Right Sinus of Valsalva. Texas Heart Institute Journal. 47(2). 170–172.
3.
Caldera, Angel, et al.. (2018). Spontaneous coronary artery dissection with left ventricular thrombus. Baylor University Medical Center Proceedings. 32(1). 99–100. 3 indexed citations
4.
Divakaran, Vijay, et al.. (2014). Pulmonary artery catheter entrapment in cardiac surgery: a simple percutaneous solution. Cardiovascular Intervention and Therapeutics. 30(4). 382–384. 1 indexed citations
5.
Divakaran, Vijay, Sarah Evans, Veli K. Topkara, et al.. (2013). Tumor Necrosis Factor Receptor–Associated Factor 2 Signaling Provokes Adverse Cardiac Remodeling in the Adult Mammalian Heart. Circulation Heart Failure. 6(3). 535–543. 29 indexed citations
6.
Divakaran, Vijay, David Yao, Saamir Hassan, et al.. (2010). Hepcidin in anemia of chronic heart failure. American Journal of Hematology. 86(1). 107–109. 31 indexed citations
7.
Ather, Sameer, L. E. Peterson, Vijay Divakaran, et al.. (2010). Digoxin treatment in heart failure — Unveiling risk by cluster analysis of DIG data. International Journal of Cardiology. 150(3). 264–269. 13 indexed citations
8.
Divakaran, Vijay, et al.. (2010). A Case of Brugada Syndrome Presenting With Incessant Polymorphic Ventricular Tachycardia. Clinical Cardiology. 33(3). E33–5. 2 indexed citations
9.
Peterson, L. E., Sameer Ather, Vijay Divakaran, et al.. (2009). Improved propensity matching for heart failure using neural gas and self-organizing maps. 19. 2517–2524.
10.
Divakaran, Vijay, Julia Adrogue, Masakuni Ishiyama, et al.. (2009). Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading. Circulation Heart Failure. 2(6). 633–642. 93 indexed citations
11.
Divakaran, Vijay, et al.. (2009). In-stent deployment of a stripped stent during percutaneous coronary intervention of a right coronary artery.. PubMed. 21(9). E180–3. 1 indexed citations
12.
McCullough, Peter A., et al.. (2008). Admission Hyperglycemia and Length of Hospital Stay in Patients With Diabetes and Heart Failure: A Prospective Cohort Study. Congestive Heart Failure. 14(3). 117–120. 12 indexed citations
13.
Divakaran, Vijay & Douglas L. Mann. (2008). The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure. Circulation Research. 103(10). 1072–1083. 214 indexed citations
14.
Sakata, Yasushi, Amanda L. Chancey, Vijay Divakaran, et al.. (2007). Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Research in Cardiology. 103(1). 60–68. 78 indexed citations
15.
Divakaran, Vijay, et al.. (2007). Bedside ultrasound diagnosis of aortic dissection in a cocaine abuser. European Journal of Internal Medicine. 18(8). 595–596. 5 indexed citations
16.
Lenihan, Daniel J., Ann T. Tong, Myrshia Woods, et al.. (2003). Withdrawal of beta blockers and ACE inhibitors in chemotherapy induced heart failure leads to severe adverse cardiovascular events. Journal of Cardiac Failure. 9(5). S77–S77. 2 indexed citations
17.
Lenihan, Daniel J., Ann T. Tong, Vijay Divakaran, et al.. (2003). Trastuzumab(T) (Herceptin) - associated cardiomyopathy: sequential stress and response to ace-inhibitors and carvedilol therapy. Journal of Cardiac Failure. 9(5). S102–S102. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026